# Biomat USA, Inc. – FDA Inspection, Jun 18, 2025

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/4d429e5b-bbcf-4e23-9e7e-3b86813807e6
Source feed: FDA_Inspections

> FDA inspection 1273078 of Biomat USA, Inc., June 18, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 640. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1273078
- Company Name: Biomat USA, Inc.
- Inspection Date: 2025-06-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Philadelphia District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1080686 - 2019-02-07
- FDA Inspection 993528 - 2016-10-20
- FDA Inspection 902871 - 2014-11-07
- FDA Inspection 796710 - 2012-08-30
- FDA Inspection 678918 - 2010-09-03

## Related Officers

- [Michele Gottshall](https://www.keypedia.com/people/michele-gottshall/f12dcaf7-8958-4591-88bb-f9746796b934)

Company: https://www.keypedia.com/companies/biomat-usa-inc/3c9739bc-e5fb-436c-b0ef-9b6e14354a7d

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8
